To better understand the role of DNMT3A R882H mutation in leukemia stem cells, the AML LSC-like cell line, KG1a, with the expression profile, CD34 + and CD38 − , was selected as our research objects [48]. The gene discussed is CD34; the disease is acute myeloid leukemia.